FilingReader Intelligence
Hansoh Pharma reports strong 2024 growth, issues final dividend
April 28, 2025 at 05:19 PM UTC•By FilingReader AI
** Hansoh Pharmaceutical Group (HKEX: 3692) released its 2024 annual report, highlighting a robust 21.3% increase in revenue, reaching RMB12.261 billion. Profit also surged, climbing 33.4% to RMB4.372 billion. The company's board has recommended a final dividend of HKD0.1353 per share, payable on July 25, 2025, to shareholders of record on July 9, 2025. Combined with the interim dividend, the full-year dividend amounts to HKD0.3363 per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HKEX:3692•Hong Kong Exchange
News Alerts
Get instant email alerts when Hansoh Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime